Oklahoma physicians must restrict initial opioid prescriptions to a seven-day supply and participate in educational training under a new law that goes into effect Nov. 1.
In addition to the supply restriction, those patients whose course of treatment includes a continuous prescription of an opioid or other Schedule II controlled substance for three months will be subject to review, according to a summary of the new law.
The new Oklahoma measure (S.B. 1446) will allow physicians to care for patients while also protecting them against addiction, Oklahoma State Medical Association President Dr. Jean Hausheer told Bloomberg Law.
“The ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.